DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Biomarkers Market Analysis By Type (Safety, Efficacy, Validation), By Application (Diagnostics, Drug Development, Personalized Medicine), By Disease (Oncology, Cardiovascular, Neurology, Immunology) And Segment Forecasts To 2024" report to their offering.
The global biomarkers market is expected to reach over USD 78.2 billion by 2024, according to this new report. The growing demand for companion diagnostics and the rising adoption of personalized medicine are the key factors propelling the growth of the biomarkers market. The increasing need of disease-specific biomarkers for the development of diagnostics, the increasing R&D funding, and the rising prevalence of oncology and cardiovascular-based diseases are anticipated to create significant opportunities for the market growth during the forecast period.
The spiraling population and the upward trend in the adoption of sedentary lifestyles are expected to provide the industry with a huge target population base. Government grants and research funding for the discovery and development of novel biomarkers are the other factors accentuating the market growth. The introduction of the biomarker-based diagnostic kits for screening high-risk population coupled with the growing prevalence of genetic disorders is also anticipated to increase the client base for this market.
- Roche Diagnostics Ltd.
- Abbott Laboratories, Inc.
- Agilent Technologies, Inc.
- Siemens Healthcare GmbH
- Epigenomics AG
- GE Healthcare
- Thermo Fisher Scientific, Inc.
- Bio-Rad Laboratories, Inc.
- Qiagen, Inc.
- Johnson & Johnson
Merck & Co., Inc.
1 Executive Summary
2 Market Snapshot
3 Market Variables, Trends & Scope
4 Market Categorization 1: Biomarker Type Estimates & Trend Analysis
5 Market Categorization 2: Biomarker Application Estimates & Trend Analysis
6 Market Categorization 3: Biomarker Disease Estimates & Trend Analysis
7 Market Categorization 4: Regional Estimates & Trend Analysis by Type, Application, and Disease
8 Competitive Landscape
For more information about this report visit http://www.researchandmarkets.com/research/8mnbnr/biomarkers_market